Odonate Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to $7,325,000 over the previous period. Total operating expenses were $796,000.
Profit Margin
| 2015 | 0 | -158K | |
|---|---|---|---|
| 2016 | 0 | -3.08M | |
| 2017 | 0 | -32.74M | |
| 2018 | 0 | -88.96M | |
| 2019 | 0 | -108.72M | |
| 2020 | 0 | -126.35M | |
| 2021 | 0 | -68.31M | |
| 2022 | 0 | 42.94M | |
| 2023 | 0 | 7.32M |
ODTC Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 21K | 342K | 1.05M | 870K | 381K | 0 | 20K | 0 | 0 |
Gross profit | -21K | -342K | -1.05M | -870K | -381K | 0 | -20K | 0 | 0 |
Operating exp. | |||||||||
Research and development | 0 | 0 | 36.48M | 117.04M | 104.03M | 79.94M | 27.90M | 2.62M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 796K | 3.57M | 45.77M | 127.43M | 114.93M | 90.76M | 32.74M | 3.08M | 158K |
Operating income | -817K | -3.91M | -46.82M | -127.43M | -114.93M | -90.76M | -32.74M | -3.08M | -158K |
Other income (expenses), net | 10.26M | 13.55M | -21.49M | 1.08M | 3.10M | 1.80M | 0 | 0 | 0 |
Income before tax | 9.44M | 9.63M | -68.31M | -126.35M | -111.82M | -88.96M | -32.74M | -3.08M | -158K |
Income tax expense | 2.11M | -33.30M | 0 | 238.70K | -3.10M | 1.80M | 0 | 0 | 0 |
Net income | 7.32M | 42.94M | -68.31M | -126.35M | -108.72M | -88.96M | -32.74M | -3.08M | -158K |
Earnings per share | |||||||||
Basic EPS | 2.56 | 14.76K | -900.72 | -1.92K | -1.79K | -1.81K | -1.15K | -221.74 | -85.62 |
Diluted EPS | 2.55 | 14.74K | -900.72 | -1.92K | -1.79K | -1.81K | -1.15K | -221.74 | -85.62 |
| Data source | Data source | Data source | Data source |